Effect of nitric oxide inhibition on immediate response to nasal allergen challenge in allergic rhinitis

M. Maniscalco, A. Stanziola, A. Molino, M. Mormile, M. Sofia, L. Carratu (Napoli, Italy)

Source: Annual Congress 2001 - Cellular immunopathology of rhinitis and asthma
Session: Cellular immunopathology of rhinitis and asthma
Session type: Thematic Poster Session
Number: 1819
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Maniscalco, A. Stanziola, A. Molino, M. Mormile, M. Sofia, L. Carratu (Napoli, Italy). Effect of nitric oxide inhibition on immediate response to nasal allergen challenge in allergic rhinitis. Eur Respir J 2001; 16: Suppl. 31, 1819

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Similar levels of nitric oxide in exhaled air in asthma and rhinitis after bronchial allergen challenge
Source: Eur Respir J 2001; 18: Suppl. 33, 269s
Year: 2001

Differences between exhaled nitric oxide levels in atopic children allergic and non allergic to cat dander
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009

Early rise in exhaled nitric oxide and mast cell activation in repeated low-dose allergen challenge
Source: Eur Respir J 2006; 27: 1152-1159
Year: 2006



Exhaled nitric oxide and bronchial hyperresponsiveness in patients with a) mild asthma and b) seasonal allergic rhinitis. Relationship to symptoms
Source: Eur Respir J 2001; 18: Suppl. 33, 165s
Year: 2001

Relationship between fractional exhaled nitric oxide and nasal symptom in allergic rhinitis
Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control
Year: 2010

Exhaled nitric oxide and lower airway involvement in persistent rhinitis
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum
Year: 2006


The impact of atopy, pollen exposure and pharmacotherapy on nasal nitric oxide levels
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010


Nitric oxide in patients with perennial allergic asthma and rhinitis
Source: Eur Respir J 2002; 20: Suppl. 38, 509s
Year: 2002

Relationship between exhaled nitric oxide and biomarkers of atopy in children with allergic rhinitis
Source: Eur Respir J 2004; 24: Suppl. 48, 271s
Year: 2004

Effect of montelukast treatment and withdrawal on exhaled nitric oxide and lung function in atopic asthmatic children
Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma
Year: 2007


Methacholine airway hyperresponsiveness is associated with fraction of nitric oxide irrespective of asthma
Source: Annual Congress 2012 - Mechanisms and risk of childhood asthma and allergy
Year: 2012

Effect of nasal allergen challenge on non-invasive markers of inflammation in allergic rhinitis
Source: Eur Respir J 2006; 28: Suppl. 50, 592s
Year: 2006

Are bronchial hyperresponsiveness and exhaled nitric oxide related in asthma? Effects of fluticasone
Source: Eur Respir J 2001; 18: Suppl. 33, 335s
Year: 2001

Comparison of late allergic inflammatory responses in asthma and rhinitis after nasal and bronchial allergen challenge
Source: Eur Respir J 2001; 18: Suppl. 33, 269s
Year: 2001

High levels of fractional exhaled nitric oxide (FeNO) only reflect the degree of allergen sensitization in mild childhood asthma
Source: Annual Congress 2005 - Monitoring paediatric asthma
Year: 2005


Atopy but no bronchial hyperresponsiveness (BHR) is related to level of exhaled nitric oxide (FeNO) in children with allergic rhinitis
Source: Annual Congress 2008 - Exercise-induced asthma, acute severe asthma and allergic rhinitis in children
Year: 2008

L-Arginine deficiency causes airway hyperresponsiveness after the late asthmatic reaction
Source: Eur Respir J 2009; 34: 191-199
Year: 2009



Montelukast as add-on therapy to β-agonists and late airway response
Source: Eur Respir J 2007; 30: 56-61
Year: 2007



Latex allergen exposure increases exhaled nitric oxide in symptomatic healthcare workers
Source: Eur Respir J 2005; 25: 309-316
Year: 2005



Inhibitors of NADPH-oxidase or nitric oxide synthase prevent airway hyperresponsiveness but not allergic inflammation in mice
Source: Eur Respir J 2001; 18: Suppl. 33, 265s
Year: 2001